Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             169 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bio-immuno assay to determine free tissue-type plasminogen activator (t-PA) in stabilyteR plasma Bos, R.
 1994
 S2 p. 163-165
3 p.
 artikel
2 A comparative study of latex d-dimer reagents Van der Planken, M.
 1994
 S2 p. 93-95
3 p.
 artikel
3 Activated protein C response and cardiovascular risk factors in the elderly — The Rotterdam Study Bots, M.L.
 1996
 S2 p. 161-164
4 p.
 artikel
4 Activation of coagulation and fibrinolysis in acute or chronic coronary artery disease Andreotti, F.
 1994
 S2 p. 122-123
2 p.
 artikel
5 Activation of coagulation and fibrinolysis in HIV-infected patients Toulon, P.
 1996
 S2 p. 59-61
3 p.
 artikel
6 Activity and antigen of saruplase and two chain urokinase related plasminogen activator are stabilized by a combination of aprotinin and benzamidine in citrated plasma Günzler, W.A.
 1990
 S2 p. 145-147
3 p.
 artikel
7 Activity of plasminogen activator inhibitor-1 (PAI-1)in a population of Northern Sweden Rånby, M.
 1990
 S2 p. 54-55
2 p.
 artikel
8 Acute exogenous hyperinsulinaemia does not result in elevation of plasma plasminogen activator inhibitor-1 (PAI-1) in humans Potter van Loon, B.J.
 1990
 S2 p. 93-94
2 p.
 artikel
9 Acute release of tissue-type plasminogen activator (t-PA) from the endothelium; regulatory mechanisms and therapeutic target Schrauwen, Y.
 1994
 S2 p. 8-12
5 p.
 artikel
10 Acute t-PA releasing effect of supersulphated low molecular weight heparins Klöcking, H.-P.
 1994
 S2 p. 75-77
3 p.
 artikel
11 A hamster pulmonary embolism model for the evaluation of the thrombolytic and pharmacokinetic properties of thrombolytic agents Stassen, J.M.
 1990
 S2 p. 15-21
7 p.
 artikel
12 Alcohol and fibrinolysis Veenstra, J.
 1990
 S2 p. 64-68
5 p.
 artikel
13 Alu-repeat polymorphism in the tissue-type plasminogen activator (t-PA) gene, t-PA levels and risk of familial myocardial infarction (MI) Iacoviello, L.
 1996
 S2 p. 13-16
4 p.
 artikel
14 A monoclonal antibody against the COOH-terminal site of α2-antiplasmin reveals heterogeneity in the non-plasminogen binding form of α2-antiplasmin Leebeek, F.W.G.
 1996
 S2 p. 67-70
4 p.
 artikel
15 Analysis of activation markers of coagulation, fibrinolysis and inflammation in unstable angina by probit transformation Biasucci, L.M.
 1996
 S2 p. 145-147
3 p.
 artikel
16 An antibody ragment against PAI-1 inhibits PAI-1 activity and stimulates fibrinolysis in vitro and in vivo Abrahamsson, T.
 1994
 S2 p. 55-56
2 p.
 artikel
17 A new adaptation of Coatest® PAI for measurements of low inhibitor concentrations in plasma Wejkum, L.
 1990
 S2 p. 130-131
2 p.
 artikel
18 An experimental system for investigation of penetration of components of the fibrinolytic system into a plasma clot Sakharov, D.V.
 1994
 S2 p. 116-119
4 p.
 artikel
19 An improved method for the detection of α 2-antiplasmin activity on the automated coagulation analyzer MLA Electra 1000C Meijer, P.
 1994
 S2 p. 160-162
3 p.
 artikel
20 A novel method, COAMATIC® Plasmin Inhibitor, for the specific determination of Plasmin Inhibitor activity in plasma Billing Clason, S.
 1996
 S2 p. 165-167
3 p.
 artikel
21 Anti-aggregatory activity of recombinant single-chain urokinase-type plasminogen activator Romanova, E.P.
 1994
 S2 p. 111-112
2 p.
 artikel
22 Application of the perfused-forearm model to study release mechanisms of tissue-type plasminogen activator in man Jem, C.
 1994
 S2 p. 13-15
3 p.
 artikel
23 Arterial disease in hyperhomocysteinaemia and the effect of treatment: A pilot study van den Berg, M.
 1994
 S2 p. 88-90
3 p.
 artikel
24 A simplified extracorporeal circuit model for the study of thrombus formation/dissolution Ford, A.J.
 1990
 S2 p. 23-25
3 p.
 artikel
25 Atherogenic lipoproteins and release of plasminogen activator inhibitor-1 (PAI-1) by endothelial cells Mussoni, L.
 1990
 S2 p. 79-81
3 p.
 artikel
26 Baseline levels of α 2-antiplasmin-plasmin complex in human plasma Meijer, P.
 1994
 S2 p. 124-125
2 p.
 artikel
27 Blood sampling and determination of tissue plasminogen activator activity with COA-SET® t-PA Wejkum, L.
 1990
 S2 p. 152-154
3 p.
 artikel
28 Body composition and weight reduction in relation to antigen and activity of plasminogen activitor inhibitor (PAI-1) in overweight individuals Huisveld, I.A.
 1990
 S2 p. 84-85
2 p.
 artikel
29 Changes in acute release of t-PA after chronic administration of n-3 polyunsaturated fatty acids into rabbits Petrukhina, G.N.
 1994
 S2 p. 53-54
2 p.
 artikel
30 Characterization of cross-linked fibrin degradation products in patients treated with fibrinolytic agents Douglas, J.T.
 1993
 S2 p. 28-31
4 p.
 artikel
31 Chromolize™ PAI-1: a new assay for active plasminogen activator inhibitor type 1 adapted for use with Stabilyte™ vials Bergsdorf, N.
 1996
 S2 p. 135-136
2 p.
 artikel
32 Circadian patterns of plasma t-PA and PAI-1 antigen levels in patients with severe peripheral atherosclerosis Andreotti, F.
 1996
 S2 p. 159-160
2 p.
 artikel
33 Clinical evaluation of D-dimer testing in disseminated intravascular coagulation (DIC) Fukutake, K.
 1993
 S2 p. 20-22
3 p.
 artikel
34 Coagulation and fibrinolysis in children with APC-resistance: a population study Nowak-Göttl, U.
 1996
 S2 p. 25-27
3 p.
 artikel
35 Comparison between functional and immunochemical assays for fibrinogen determination in a family cohort study Siegert, G.
 1996
 S2 p. 129-131
3 p.
 artikel
36 Comparison of specificities of antigen assays for plasminogen activator inhibitor 1(PAI-1) Kluft, C.
 1990
 S2 p. 136-137
2 p.
 artikel
37 Comparison of the specificity of four fibrinogen assays during thrombolytic therapy Hoffmann, J.J.M.L.
 1990
 S2 p. 121-123
3 p.
 artikel
38 Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAT-1): Conditions and therapeutic targets Kluft, C.
 1994
 S2 p. 1-7
7 p.
 artikel
39 Correlation between ECLT, t-PA and PAM activity and antigen levels in healthy volunteers Dávid, M.
 1994
 S2 p. 31-33
3 p.
 artikel
40 Criteria for a specific plasmin inhibition test (SPIT) in human plasma Meijer, P.
 1996
 S2 p. 121-123
3 p.
 artikel
41 D-dieter during intra-arterial low-dose streptokinase treatment of peripheral arterial occlusive disease Stegnar, M.
 1994
 S2 p. 105-107
3 p.
 artikel
42 D-dimer antibodies. Powerful reagents for the study of human thrombosis and fibrinolysis Rowbotham, B.
 1993
 S2 p. 9-11
3 p.
 artikel
43 D-dimer. History of the discovery, characterisation and utility of this and other fibrin fragments Gaffney, P.J.
 1993
 S2 p. 2-8
7 p.
 artikel
44 Decreased serum tetranectin in multiple myeloma — relation to disease stage Steiner, M.
 1996
 S2 p. 105-107
3 p.
 artikel
45 Determination of plasminogen activator inhibitor in human plasma and blood platelets and its clinical relevance Griep, E.N.
 1990
 S2 p. 141-144
4 p.
 artikel
46 Development of an internal standard for plasminogen activator inhibitor-1 PAI-1 and its use in a simplified assay for measuring pai-1 activity in human plasma Angles-Cano, E.
 1990
 S2 p. 127-129
3 p.
 artikel
47 Dextransulfate (DS) stimulated fibrinolytic activity in relation to the activity of tissue plasminogen activator (t-pa) and single and two chain urinary type plasminogen activator [(sc + tc) u-PA] Himmelreich, G.
 1990
 S2 p. 150-151
2 p.
 artikel
48 Disseminated intravascular coagulation: Pathophysiology and laboratory diagnosis Bovill, E.G.
 1993
 S2 p. 17-19
3 p.
 artikel
49 Does a negative D-dimer exclude thrombosis? Eisenberg, P.R.
 1993
 S2 p. 32-35
4 p.
 artikel
50 Dog model for thrombolysis in acute ischemic stroke Hirschberg, M.
 1990
 S2 p. 9-11
3 p.
 artikel
51 DVT exclusion in symptomatic outpatients: use of a rapid D-dimer immunofiltration assay and comparison with three enzyme immuno assays Pannocchia, A.
 1996
 S2 p. 117-119
3 p.
 artikel
52 Effect of caffeine intake on platelet antigen levels of plasminogen activator inhibitor-1 (PAI-1) Joerg, M.
 1990
 S2 p. 71-73
3 p.
 artikel
53 Effect of diet on fibrinolytic components. An introduction Emeis, J.J.
 1990
 S2 p. 59-60
2 p.
 artikel
54 Effect of fish oil and vitamin E on the cardiovascular risk indicators fibrinogen, C-reactive protein and PAI activity in healthy young volunteers de Maat, M.P.M.
 1994
 S2 p. 50-52
3 p.
 artikel
55 Effect of long-term administration of cholestyramine on the fibrinolytic system in rabbits Klöcking, H.-P.
 1990
 S2 p. 41-43
3 p.
 artikel
56 Effect of low density lipoproteins on secretion of plasminogen activator inhibitor-1 (PAI-1) by human endothelial cells and hepatoma cells Latron, Y.
 1990
 S2 p. 82-83
2 p.
 artikel
57 Effects of coffee and caffeine on tissue-type plasminogen activator and its fast-acting inhibitor, PAI-1, in vivo and in vitro Kluft, C.
 1990
 S2 p. 74-75
2 p.
 artikel
58 Effects of infection with recombinant adenovirus on human vascular endothelial and smooth muscle cells Quax, P.H.A.
 1996
 S2 p. 71-74
4 p.
 artikel
59 Effects of long-distance running on hemostasis and fibrinolysis Hellstern, P.
 1990
 S2 p. 99-101
3 p.
 artikel
60 Effects of low-molecular weight and high-molecular weight heparin on the intrinsic and extrinsic endogenous fibrinolytic system Dechend, R.
 1994
 S2 p. 71-74
4 p.
 artikel
61 Effects of psychosocial stress on the fibrinolytic system in man Tengbom, L.
 1990
 S2 p. 110-112
3 p.
 artikel
62 Effects of self-administration of high doses androgenic-anabolic steroids on fibrinolytic activity in non elite bodybuilders Pernot, C.
 1996
 S2 p. 53-54
2 p.
 artikel
63 Elevated fibrinolysis in cardiopulmonary bypass is factor XII dependent Chung, H.I.
 1994
 S2 p. 84-85
2 p.
 artikel
64 Endothelial vWf and t-PA release after incubation with different concentrations of asparaginase and dexamethasone Nowak-Göttl, U.
 1996
 S2 p. 55-56
2 p.
 artikel
65 Enhanced soluble thrombomodulin, t-PA and u-PA concentrations caused by short-term endothelial damage during percutaneous cardiac catheterisation Vielhaber, H.
 1996
 S2 p. 47-49
3 p.
 artikel
66 Enhanced thrombin generation, P-von willebrand factor, P-fibrin D-dimer and P-plasminogen activator inhibitor 1: Predictive for venous thrombosis in asparaginase-treated children Nowak-Göttl, U.
 1994
 S2 p. 63-65
3 p.
 artikel
67 Epidemiology and fibrinolysis Haverkate, F.
 1990
 S2 p. 49-50
2 p.
 artikel
68 Evaluation of blood sampling for the measurement of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor activity (PAI-1) van der Heide, Y.T.
 1994
 S2 p. 152-153
2 p.
 artikel
69 External quality assessment of thrombophilia testing in Europe Haverkate, F.
 1996
 S2 p. 169-169
1 p.
 artikel
70 Factors affecting the relation between plasminogen activator inhibitor (PAI) activity and PAI-1 antigen levels in normals and in patients with arterial disease Andreotti, F.
 1990
 S2 p. 134-135
2 p.
 artikel
71 Factor VII coagulant activity is related to blood lipids in the elderly. The Rotterdam study van der Bom, J.G.
 1994
 S2 p. 132-134
3 p.
 artikel
72 Factor XII dependent fibrinolytic activity is decreased in the acute phase of myocardial or cerebral infarction Spannagl, M.
 1996
 S2 p. 51-52
2 p.
 artikel
73 Fibrinogen and associations with risk factors for cardiovascular disease Miller, L.
 1990
 S2 p. 56-58
3 p.
 artikel
74 Fibrinolytic agents in animal models of cerebrovascular ischemia del Zoppo, G.J.
 1990
 S2 p. 3-7
5 p.
 artikel
75 Fibrinolytic capacity and risk of myocardial infarction van der Bom, J.G.
 1996
 S2 p. 9-12
4 p.
 artikel
76 Fibrinolytic response to venous occlusion in diabetics with and without microangiopathy compared to normal age and sex matched controls McLaren, M.
 1990
 S2 p. 95-96
2 p.
 artikel
77 Fibrin turnover in plasma and peritoneal dialysis effluent of capd patients with and without peritonitis Goedde, M.
 1994
 S2 p. 120-121
2 p.
 artikel
78 Fragmentation pattern of fibrinogen during thrombolysis in acute myocardial infarction with fibrin-specific plasminogen activators — Detection of high-molecular weight fibrinogen degradation products Dechend, R.
 1994
 S2 p. 102-104
3 p.
 artikel
79 Frequent sampling by clear venipuncture in unstable angina is a reliable method to assess haemostatic system activity Biasucci, L.M.
 1994
 S2 p. 142-144
3 p.
 artikel
80 Functional variants in candidate genes involved in vascular matrix remodelling Henney, A.M.
 1996
 S2 p. 3-5
3 p.
 artikel
81 Gaps between the present assay practice in haemostasis and clinical chemistry laboratories Jespersen, J.
 1990
 S2 p. 118-120
3 p.
 artikel
82 Genetic and environmental determinants of factor VII, fibrinogen and PAI-1 Green, F.R.
 1996
 S2 p. 7-8
2 p.
 artikel
83 Genetic studies of complex diseases: giant steps from promise to proof Slagboom, P.E.
 1996
 S2 p. 1-2
2 p.
 artikel
84 Genetic variation at the plasminogen activator inhibitor-1 (PAI-1) locus Dawson, S.
 1990
 S2 p. 51-53
3 p.
 artikel
85 Impact of physical training on plasminogen activator inhibitor activity in sedentary men Gris, J.C.
 1990
 S2 p. 97-98
2 p.
 artikel
86 Increased concentration of plasminogen activator inhibitor type-1 in plasma after intake of fish oil Müllertz, A.
 1990
 S2 p. 86-88
3 p.
 artikel
87 Increased plasmin generation and activity in hiv-infected patients: In vivo rather than in vitro activation of the fibrinolytic system Toulon, P.
 1994
 S2 p. 128-131
4 p.
 artikel
88 Influence of blood handling on determination of plasma resistance against activated protein C Pedersen, O.D.
 1996
 S2 p. 153-154
2 p.
 artikel
89 Influence of mental stress on fibrinogen, von Willebrand factor and tissue-type plasminogen activator antigen Snieder, H.
 1996
 S2 p. 137-139
3 p.
 artikel
90 Influence of time, temperature and anticoagulants on the determination of t-PA activity Eriksson, E.
 1994
 S2 p. 150-151
2 p.
 artikel
91 Influence of two different e.coli asparaginase preparations on coagulation and fibrinolysis: A randomized trial Nowak-Göttl, U.
 1994
 S2 p. 66-68
3 p.
 artikel
92 Inhibition of coagulation and fibrinolysis by aprotinin in patients undergoing cardio-pulmonary bypass surgery Spannagl, M.
 1994
 S2 p. 82-83
2 p.
 artikel
93 Inhibition of urokinase-type and tissue-type plasminogen activator — mediated plasminogen activation by doxycycline Hanemaaijer, R.
 1996
 S2 p. 109-111
3 p.
 artikel
94 Interference of ϵ-amino-caproic acid with [N-succinimidyl S-acetylthioacetate derived] thiol-introduction into glu-plasminogen Heeremans, J.L.M.
 1994
 S2 p. 138-141
4 p.
 artikel
95 Intraperitoneal coagulation and fibrinolysis during inflammation: In vivo and in vitro observations Sitter, T.
 1996
 S2 p. 99-104
6 p.
 artikel
96 Introduction to diet and endogenous fibrinolysis Marckmann, P.
 1994
 S2 p. 37-40
4 p.
 artikel
97 Introduction to the: Leiden workshop on animal models in fibrinolysis and thrombolysis and ‘in vitro’ alternatives Emeis, J.J.
 1990
 S2 p. 1-
1 p.
 artikel
98 Isolation and storage of DNA for population studies Droog, S.
 1996
 S2 p. 29-30
2 p.
 artikel
99 Leiden fibrinolysis working party: blood collection and handling procedures for assessment of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) Kluft, C.
 1990
 S2 p. 155-161
7 p.
 artikel
100 Life style and blood fibrinolytic activity: a comment on clearance of plasminogen activators de Boer, A.
 1990
 S2 p. 61-63
3 p.
 artikel
101 Localization of the components of the plasminogen activation system in cutaneous melanocytic lesions — a minireview de Vries, T.J.
 1996
 S2 p. 91-94
4 p.
 artikel
102 Measurement of different forms of plasminogen activator inhibitor 1(PAI-1) using various monoclonal antibody-based enzyme-linked immunosorbent assays Declerck, P.J.
 1990
 S2 p. 132-133
2 p.
 artikel
103 Measurement of β-thromboglobulin in the elderly. Findings from the Rotterdam study van der Bom, J.G.
 1994
 S2 p. 157-159
3 p.
 artikel
104 Molecular characteristics of human plasma, platelet and vascular cell PAI-1. Comparison between normal and thrombocytemic subjects Pannocchia, A.
 1994
 S2 p. 28-30
3 p.
 artikel
105 NASBA® factor V Leiden QL; a new genotype assay to detect the factor V Leiden mutation in anticoagulated whole blood Roeles, F.
 1996
 S2 p. 31-32
2 p.
 artikel
106 New aspects of blood collection and handling procedures for the assessment of t-PA and PAI-1 variables after the introduction of acid blood collection Meijer, P.
 1994
 S2 p. 145-147
3 p.
 artikel
107 Non-esterified fatty acids are related with hypofibrinolysis in type 2 diabetes mellitus Brussaard, H.E.
 1994
 S2 p. 25-27
3 p.
 artikel
108 PADMA-28, a botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication Winther, K.
 1994
 S2 p. 47-49
3 p.
 artikel
109 PAI-1 reduction after treatment with glutathione in NIDDM Martina, V.
 1996
 S2 p. 63-65
3 p.
 artikel
110 Pathobiochemical implications of hyperhomocysteinemia Blom, H.J.
 1994
 S2 p. 86-87
2 p.
 artikel
111 Pharmacological stimulation of t-PA release in rats Klöcking, H.-P.
 1990
 S2 p. 45-46
2 p.
 artikel
112 Plasma factor VII levels are determined by polymorphisms in the factor VII gene Bentzen, J.
 1996
 S2 p. 17-18
2 p.
 artikel
113 Plasma plasminogen activator levels increase progressively during prolonged exercise Potter van Loon, B.J.
 1990
 S2 p. 102-104
3 p.
 artikel
114 Plasmin-antiplasmin complexes in prognostic evaluation of patients with unstable angina Biasucci, L.M.
 1994
 S2 p. 126-127
2 p.
 artikel
115 Plasmin α 2 antiplasmin complex in three different asparaginase treatment regimens in childhood leukemia Risseeuw-Appel, I.M.
 1994
 S2 p. 69-70
2 p.
 artikel
116 Plasmin-induced endothelium-dependent vasodilatation versus fibrinolysis — Two pathways of blood flow restoration in the thrombotically occluded vessels? Mashina, S.Y.
 1994
 S2 p. 113-115
3 p.
 artikel
117 Plasminogen activator inhibitor I response to a carbohydrate meal in obese subjects Medvešcek, M.
 1990
 S2 p. 89-90
2 p.
 artikel
118 Plasminogen activator regulation studies following transfection of human endothelial cells Hanemaaijer, R.
 1994
 S2 p. 19-21
3 p.
 artikel
119 Preface The Organizing Communittee,
 1994
 S2 p. ii-
1 p.
 artikel
120 Quality control in quantitation of components of the plasminogen activator system in tumour extracts Benraad, Th.J.
 1996
 S2 p. 149-151
3 p.
 artikel
121 Quantitative immunological determination of human fibrin- and fibrinogen-degradation products (FDP) in plasma with an antibody against a synthetic peptide Kraus, M.
 1994
 S2 p. 99-101
3 p.
 artikel
122 Regular moderate wine consumption for five weeks increases plasma activity of the plasminogen activator inhibitor-1 (PAI-1) in healthy young volunteers Kluft, C.
 1990
 S2 p. 69-70
2 p.
 artikel
123 Relation of plasminogen activator inhibitor-1 activity and plasminogen activator inhibitor-1 concentration in different plasma samples Siegert, G.
 1994
 S2 p. 154-156
3 p.
 artikel
124 Relation of tissue-type plasminogen activator and plasminogen activator inhibitor to metabolic variables and atherosclerosis in a family cohort study Siegert, G.
 1996
 S2 p. 141-143
3 p.
 artikel
125 Relationship of plasminogen activator inhibitor activity and tissue-type plasminogen activator concentration with age, sex, risk factors for coronary heart disease and life style Siegert, G.
 1994
 S2 p. 34-36
3 p.
 artikel
126 Resistance to activated protein C evaluated with APTT-based methods and DNA analysis Pannocchia, A.
 1996
 S2 p. 21-23
3 p.
 artikel
127 Retinoic acid restores reduced fibrinolytic activity in vitamin A deficient rats but does not enhance fibrinolytic activity in normal rats Jansen, J.W.C.M.
 1994
 S2 p. 78-79
2 p.
 artikel
128 Role of urokinase plasminogen activator in human breast cancer: Active involvement of stromal fibroblasts van Roozendaal, C.E.P.
 1996
 S2 p. 79-83
5 p.
 artikel
129 Seasonal variation in fibrinolysis in patients with rheumatoid arthritis McLaren, M.
 1990
 S2 p. 116-117
2 p.
 artikel
130 Shift work and circadian rhythm of blood fibrinolytic parameters Peternel, P.
 1990
 S2 p. 113-115
3 p.
 artikel
131 Some characteristics of commercially available human glu-plasminogen preparations Nagel, A.
 1994
 S2 p. 135-137
3 p.
 artikel
132 Specificity of functional determination of urokinase in human plasma using selective oxidants Stief, T.W.
 1990
 S2 p. 148-149
2 p.
 artikel
133 Stable enhancement of tissue-type plasminogen activator levels in blood: Interrupted chamber hypoxia mimics effects of alpine hypoxia Bashkov, G.V.
 1994
 S2 p. 80-81
2 p.
 artikel
134 Study design for the identification of loci affecting human longevity Heijmans, B.T.
 1996
 S2 p. 19-20
2 p.
 artikel
135 Symposium — D-dimer from laboratory to bedside Gaffney, P.J.
 1993
 S2 p. 1-
1 p.
 artikel
136 Systemic fibrinolytic effect of pulse spray thrombolysis with tissue-type plasminogen activator (rt-PA) Yusuf, S.W.
 1994
 S2 p. 108-110
3 p.
 artikel
137 The activity of plasminogen activator inhibitor-1 (PAI-1) of human platelet Booth, N.A.
 1990
 S2 p. 138-140
3 p.
 artikel
138 The decrease of plasminogen activator inhibitor after normalization of triglycerides during treatment with fibrates Keber, I.
 1994
 S2 p. 57-59
3 p.
 artikel
139 The effect of diets, rich in mono- or polyunsaturated fatty acids, on lipid metabolism and haemostasis Heinrich, J.
 1990
 S2 p. 76-78
3 p.
 artikel
140 The effect of fasting and/or body weight reduction on tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) Petemel, P.
 1994
 S2 p. 41-43
3 p.
 artikel
141 The effect of gliclazide on plasma urokinase-related fibrinolysis. The results from an exploratory study Gram, J.
 1994
 S2 p. 60-62
3 p.
 artikel
142 The effect of hypoxia during exercise on release of tissue-type plasminogen activator (t-PA) Stegnar, M.
 1990
 S2 p. 108-109
2 p.
 artikel
143 The effect of oat husk supplementation in diet on plasminogen activator inhibitor type 1 in diabetic survivors of myocardial infarction Gužič, B.
 1994
 S2 p. 44-46
3 p.
 artikel
144 The effect of percutaneous transluminal coronary angioplasty on haemostasis Várnai, K.
 1996
 S2 p. 37-40
4 p.
 artikel
145 The effect of the relationship between tissue-type plasminogen activator and plasminogen activator inhibitor type 1 on tissue-type plasminogen activator activity in insulin-dependent diabetes mellitus Myrup, B.
 1994
 S2 p. 22-24
3 p.
 artikel
146 The effect of treatment of Helicobacter pylori infection on gastric mucosal plasminogen activators Götz, J.M.
 1996
 S2 p. 85-89
5 p.
 artikel
147 The influence of centrifugation load on platelet number and PAI-1 antigen concentration in human plasma Sidelmann, J.
 1994
 S2 p. 148-149
2 p.
 artikel
148 The influence of metformin on the fibrinolytic system and insulin resistance in patients with hypertension Tengbom, L.
 1990
 S2 p. 91-92
2 p.
 artikel
149 The influence of venepuncture, mixing and separation of blood on the measurement of thrombin-antithrombin-III-complex and plasminogen activator inhibitor Sidelmann, J.
 1990
 S2 p. 124-126
3 p.
 artikel
150 The plasminogen activation system in rheumatoid arthritis Ronday, H.K.
 1996
 S2 p. 95-98
4 p.
 artikel
151 The radial immunodiffusion assay for plasma Histidine-rich Glycoprotein (HRG) based on a polyclonal antibody, shows a different specificity towards the two variants of a common amino acid polymorphism Hennis, B.C.
 1996
 S2 p. 133-134
2 p.
 artikel
152 The role of plasminogen activators in the development of atherosclerotic and restenotic lesions Lupu, F.
 1996
 S2 p. 33-35
3 p.
 artikel
153 The specificity and sensitivity of latex and ELISA methods for fibrin degradation products in the diagnosis of myocardial infarction Douglas, J.T.
 1994
 S2 p. 96-98
3 p.
 artikel
154 The use of cultured human endothelial cells and hepatocytes as an in vitro model system to study modulation of endogenous fibrinolysis Kooistra, T.
 1990
 S2 p. 33-39
7 p.
 artikel
155 The use of Stabilyte® plasma may cause changes in pH in the assay of some fibrinolysis analytes and might effect results Meijer, P.
 1996
 S2 p. 155-157
3 p.
 artikel
156 Thrombin receptor and urokinase-type plasminogen activator are colocalized in vascular smooth muscle cells derived from human carotid atherosclerotic plaques Dechend, R.
 1996
 S2 p. 41-44
4 p.
 artikel
157 Thrombolytic activity of defibrotide against 1-, 3-, 7- or 10-day-old venous thrombi Porta, R.
 1990
 S2 p. 27-31
5 p.
 artikel
158 Thrombolytic therapy in stroke — A rat model Overgaard, K.
 1990
 S2 p. 13-14
2 p.
 artikel
159 Tissue-type plasminogen activator and plasminogen activator inhibitor-1 after exercise: comparison to venous occlusion and DDAVP Vene, N.
 1990
 S2 p. 105-107
3 p.
 artikel
160 t-PA activity and antigen in thrombolytic treatment with rt-PA in children Risseeuw-Appel, I.M.
 1996
 S2 p. 57-58
2 p.
 artikel
161 Transgenic mice carrying a human t-pa promoter — lacZ reporter gene: A model for the study of pharmacological modulation of fibrinolytic potential Theuring, F.
 1994
 S2 p. 16-18
3 p.
 artikel
162 Update 1996: Blood collection and handling procedures for assessment of plasminogen activators and inhibitors (Leiden Fibrinolysis Workshop) Kluft, C.
 1996
 S2 p. 171-179
9 p.
 artikel
163 Urokinase and tissue-type plasminogen activator stimulate human vascular smooth muscle cell migration Wijnberg, M.J.
 1996
 S2 p. 75-78
4 p.
 artikel
164 Usefulness and limitations of actilyse® for standardisation of tissue-type plasminogen activator (t-PA) assays in blood Huisman, L.G.M.
 1996
 S2 p. 125-127
3 p.
 artikel
165 Utility of D-dimer measurement in deep venous thrombosis Devine, D.V.
 1993
 S2 p. 12-16
5 p.
 artikel
166 Value of D-dimer measurement in arterial thrombosis and after angioplasty Jørgensen, B.
 1993
 S2 p. 23-27
5 p.
 artikel
167 Various approaches to standardization and the importance of measurement accuracy Gram, J.
 1996
 S2 p. 113-116
4 p.
 artikel
168 Will a decrease of blood homocysteine by vitamin supplementation reduce the risk for vascular disease? den Heijer, M.
 1994
 S2 p. 91-92
2 p.
 artikel
169 25 year Gaubius Institute TNO Brakman, P.
 1990
 S2 p. 47-48
2 p.
 artikel
                             169 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland